Has Khaldoun Tarakji received payments from drug or device companies?

Yes. Drug and device makers reported $62,320 in general payments to Khaldoun Tarakji across 102 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khaldoun Tarakji did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khaldoun Tarakji come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khaldoun Tarakji

Cardiovascular Disease · Cleveland, OHNPI 1356517957

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 79.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $25,391 and has fallen 77.8% since, to $5,625 in 2022. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,320in general payments, 2019–2025

Across 102 payments — averaging $610.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$50K
E.r. Squibb & Sons, L.L.C.$4K
Pfizer$4K
Boston Scientific$4K
Janssen Scientific Affairs, LLC$650
Biosense Webster, Inc.$273
plus $259 from 1 others

$270,337in research payments, 2019–2025

Across 38 payments — averaging $7114.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$224K
Irhythm Technologies, Inc.$39K
Janssen Scientific Affairs, LLC$7K

What the payments were for

Consulting fees$23,57038%
Speaking & faculty fees$24,58039%
Travel & lodging$7,60912%
Food & beverage$3,2885%
Education$3,2745%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	84	$49,521
E.r. Squibb & Sons, L.L.C.	1	$4,165
Pfizer	1	$3,780
Boston Scientific	10	$3,672
Janssen Scientific Affairs, LLC	2	$650
Biosense Webster, Inc.	2	$273
Abbott	2	$259

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TYRX$9,289
ELIQUIS$3,780
Arctic Front$2,300
GENERAL - THERAPIES$2,248
LATITUDE$1,260
CoreValve Evolut$1,115
XARELTO$600
CareLink$418
EnSite Precision Cardiac Mapping System$202
Carto 3 System$199

How this compares

$62,320 in reported general payments places this provider in the 90th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio →

Other cardiovascular disease in Cleveland

Guilherme AttizzaniCleveland$1.3M
Abraham LincoffCleveland$369K
Oussama WazniCleveland$367K
Ian NeelandCleveland$329K
Mazen HannaCleveland$208K
Brian HoitCleveland$207K
Steven NissenCleveland$149K
Daniel CantillonCleveland$140K
Serge HarbCleveland$134K
Wael JaberCleveland$124K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →